Oxilan® is a radiographic contrast agent used in diagnostic imaging studies. The degree of contrast enhancement is directly related to the iodine content in the administered dose. Dependent on the iodine content, the osmolalities are 2.1 or 2.4 times that of plasma (285 mOsm/kg water).

Digital images can be manipulated for evaluation in various ways. Post-processing includes: Subtraction, addition, rotation, inversion, multiplanar reconstruction (MPR), maximum intensity projection (MIP), etc.
Subtraction is particularly useful in contrast enhanced examinations. The pre contrast images are subtracted from the images after an injection of contrast agents (sometimes also called dye) for better tumor detection. See also Contrast Enhanced Computed Tomography, Digital Subtraction Angiography and Active Zone.

Radiopaque materials are not penetrable by radiation or impede x-rays. Radiopaque substances appear white on radiographic images.

See also Contrast Agents.

See Contrast Agents and Dye.

Reno-30® is a radiopaque contrast agent indicated for retrograde or ascending pyelography. Retrograde pyelography does not include systemic administration of contrast media, so the risk of adverse reactions is extremely rare.